• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Early-stage

HTGF and IFH back KSK Diagnostics
HTGF and IFH back KSK Diagnostics

New funding will be used to develop point-of-care tests by utilising isothermal amplification technology

  • Early-stage
  • 25 April 2017
TGFS and Hessen Kapital back Mapcase
TGFS and Hessen Kapital back Mapcase

New capital will be used to improve the technology, as well as expand operations in the DACH region

  • Early-stage
  • 20 April 2017
Atlantic Labs leads funding round for Peat
Atlantic Labs leads funding round for Peat

VC leads a seven-digit funding round for the German plant disease diagnostic app developer

  • Early-stage
  • 20 April 2017
Bayern Kapital backs Terraloupe
Bayern Kapital backs Terraloupe

New capital will be used to build the product platform and expand the business internationally

  • Early-stage
  • 11 April 2017
IBB, WestTech et al. in €1.5m seed round for Fliit
IBB, WestTech et al. in €1.5m seed round for Fliit

Company plans to adapt its distribution system to expand into other areas

  • Early-stage
  • 05 April 2017
Ananda leads £2.5m series-A round for Repositive
Ananda leads £2.5m series-A round for Repositive

Other investors include Amadeus Capital Partners and Force Over Mass Capital

  • Early-stage
  • 04 April 2017
Auriga, Kreaxi, Alto in €2.4m round for Nosopharm
Auriga, Kreaxi, Alto in €2.4m round for Nosopharm

Nosopharm has raised a total of €4.2m in equity funding to date

  • Early-stage
  • 28 March 2017
Tengelmann et. al in second round for Ottonova
Tengelmann et. al in second round for Ottonova

Ottonova will use the extra capital to continue to develop and launch its health insurance platform

  • Early-stage
  • 27 March 2017
SR One leads $30m series-B for Pulmocide
SR One leads $30m series-B for Pulmocide

Company will use the extra funding to put its treatments through early clinical development

  • Early-stage
  • 21 March 2017
Rothschild et al. lead €34.4m series-B for MedLumics
Rothschild et al. lead €34.4m series-B for MedLumics

New VC investors participated in the round, including Italian GP Innogest and Ireland-based Seroba Life Sciences

  • Early-stage
  • 21 March 2017
Irdi Soridec leads €16m funding round for Advicenne
Irdi Soridec leads €16m funding round for Advicenne

Cemag Invest and MI Care also took part in the funding round for the French pharmaceutical business

  • Early-stage
  • 20 March 2017
HTGF, Bayern Kapital in €3m series-B for Fazua
HTGF, Bayern Kapital in €3m series-B for Fazua

Company will use the funding to set up production operations in Munich and deliver first orders

  • Early-stage
  • 15 March 2017
Gimv, Sofinnova in €43.5m round for Breath Therapeutics
Gimv, Sofinnova in €43.5m round for Breath Therapeutics

Company will use the financing to conduct phase III trials of its inhalation therapy in Europe and the US

  • DACH
  • 08 March 2017
Vesalius leads €8.3m series-B for Omeicos
Vesalius leads €8.3m series-B for Omeicos

Backers in the investment round include KfW Bank, IBB Beteiligungsgesellschaft and Hich-Tech Gründerfonds

  • Early-stage
  • 01 March 2017
Mosaic and Ribbit lead €5.5m series-A for Bonify
Mosaic and Ribbit lead €5.5m series-A for Bonify

Two VCs join existing backers Index Ventures, DN Capital and HW Capital

  • Early-stage
  • 23 February 2017
KDev et al. invest SEK 32m in Modus
KDev et al. invest SEK 32m in Modus

Developer of sickle cell disease treatments recently rebranded from Dilaforette and announced intention to float

  • Early-stage
  • 20 February 2017
HTGF backs Wetransform
HTGF backs Wetransform

German early-stage VC investor expands in the spatial data system market

  • Early-stage
  • 14 February 2017
Forbion, Seroba co-lead €29m series-B for Prexton
Forbion, Seroba co-lead €29m series-B for Prexton

Backers include existing investors Merck Ventures, Ysios Capital and Sunstone Capital

  • Early-stage
  • 09 February 2017
Seed Capital. Spar Nord invest DKK 5m in Ernit
Seed Capital. Spar Nord invest DKK 5m in Ernit

Danish bank will take an active role in launching the product in Denmark

  • Early-stage
  • 06 February 2017
KPN leads €5m seires-B for Personal MedSystems
KPN leads €5m seires-B for Personal MedSystems

Backers include German lender NRW Bank, Seventure and High-Tech Gründerfonds

  • Early-stage
  • 31 January 2017
Invitalia leads €700,000 round for Remoria VR
Invitalia leads €700,000 round for Remoria VR

Backers include Italian venture capital house LVentures Group and several business angels

  • Early-stage
  • 16 January 2017
EMBL, Life Sciences Partners lead €8m series-A for Luxendo
EMBL, Life Sciences Partners lead €8m series-A for Luxendo

GPs completed the funding round launched in 2015 with an additional €2m injection

  • Early-stage
  • 12 January 2017
Boehringer Ingelheim leads €9m series-A for Heparegenix
Boehringer Ingelheim leads €9m series-A for Heparegenix

Backers to the funding round include Novo Seeds and High-Tech Gründerfonds

  • Early-stage
  • 12 January 2017
Caixa, Kereon lead €2.5m round for Transplant Biomedicals
Caixa, Kereon lead €2.5m round for Transplant Biomedicals

Deal marks the second round led by the two investors for the Spanish business

  • Early-stage
  • 12 January 2017
192021
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013